Rossitto Erica reported option exercise involving 5,040 derivative units of HCA Healthcare, Inc. at $0.00 for $0 on Nov 6, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
SVP & Chief Nurse Executive
SVP & Chief Nurse Executive
Filed Nov 10, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
5,040Stock Appreciation Right
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
0Direct
Trade date
Nov 6, 2026Option exercise
Filed
Nov 10, 2026, 5:09 PM ET4-day reporting delay
Accession
0001193125-26-455721Code M · Transaction 397318
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Related trades are temporarily unavailable. Open the SEC filing for the complete report, or reload this page.

HCA price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
HCA · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 17, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −14%1w ago −14%1d ago +0.6%
Returns since7d30d90d180d1y

Footnotes in full

F1: The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018. F2: The stock appreciation rights vested in four equal annual installments beginning on January 31, 2019.